MCAM and breast cancer: This is consistent with our in vitro data, whereby reduction of MCAM expression in the MDA-MB-231 cells, a breast cancer cell line with mesenchymal characteristics (Taube et al., 2010; Zeng et al., 2012), enhanced its invasiveness.